
Sign up to save your podcasts
Or


In the midst of reporting season, it's often easy to forget about the long-term potential of some of the market's great compounders.
Last week, we saw stocks like Megaport (ASX: MP1) and Altium (ASX: ALU) soar 20% in one day on the back of their results, while stocks that disappointed, like Ramsay Health Care (ASX: RHC) and Iluka Resources (ASX: ILU), were punished by the market.
But by looking through quarterlies, half yearlies and full-year results, investors can see the bigger picture.
Companies like REA Group (ASX: REA) have returned 345% over the past 10 years, while Fortescue Metals Group (ASX: FMG) has lifted 378%, Xero (ASX: XRO) has soared 706%, and Pro Medicus (ASX: PME) has skyrocketed 15,054%. Over that same time period, the ASX All Ordinaries has only lifted 43% (and the benchmark tracking Australia's biggest companies, the ASX 200, has risen 39%).
So in this episode, Livewire's Ally Selby was joined by LSN Capital Partners' Nick Sladen and Elvest's Adrian Ezquerro for their tips for finding the best growth opportunities over the next decade.
Plus, they also name seven companies for above-market returns over the years ahead.
Note: This episode was filmed on Wednesday 23 August 2023. You can read an edited transcript below:
https://www.livewiremarkets.com/wires/7-growth-stocks-for-the-next-10-years
By Livewire MarketsIn the midst of reporting season, it's often easy to forget about the long-term potential of some of the market's great compounders.
Last week, we saw stocks like Megaport (ASX: MP1) and Altium (ASX: ALU) soar 20% in one day on the back of their results, while stocks that disappointed, like Ramsay Health Care (ASX: RHC) and Iluka Resources (ASX: ILU), were punished by the market.
But by looking through quarterlies, half yearlies and full-year results, investors can see the bigger picture.
Companies like REA Group (ASX: REA) have returned 345% over the past 10 years, while Fortescue Metals Group (ASX: FMG) has lifted 378%, Xero (ASX: XRO) has soared 706%, and Pro Medicus (ASX: PME) has skyrocketed 15,054%. Over that same time period, the ASX All Ordinaries has only lifted 43% (and the benchmark tracking Australia's biggest companies, the ASX 200, has risen 39%).
So in this episode, Livewire's Ally Selby was joined by LSN Capital Partners' Nick Sladen and Elvest's Adrian Ezquerro for their tips for finding the best growth opportunities over the next decade.
Plus, they also name seven companies for above-market returns over the years ahead.
Note: This episode was filmed on Wednesday 23 August 2023. You can read an edited transcript below:
https://www.livewiremarkets.com/wires/7-growth-stocks-for-the-next-10-years

11 Listeners

89 Listeners

22 Listeners

43 Listeners

9 Listeners

14 Listeners

64 Listeners

30 Listeners

23 Listeners

4 Listeners

27 Listeners

30 Listeners

5 Listeners

15 Listeners

16 Listeners